GSA Capital Partners »

Acrivon Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $260k 187k 1.39

More positions owned by GSA Capital Partners

Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Spdr Series Trust State Street Spd (JNK)
Spdr Series Trust State Street Spd (SPSB)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Bank Ozk (OZK)
Star Bulk Carriers Corp. Shs Par (SBLK)
Spdr Series Trust State Street Spd (SPIB)
Ameriprise Financial (AMP)
Synchrony Financial (SYF)
Alphabet Cap Stk Cl A (GOOGL)
Frontline (FRO)

View all positions for GSA Capital Partners

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Wellington Management Company
Acadian Asset Management
Vanguard Capital Management
Vanguard Group
Renaissance Technologies
Marshall Wace
Acorn Capital Advisors
Two Sigma Investments
Jane Street
Geode Capital Management
BlackRock
GSA Capital Partners
Vanguard Fiduciary Trust

View all funds holding Acrivon Therapeutics